|
|
||||||||
The FASEB Journal, Vol 6, 2561-2567, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
FJ Walker and PJ Fay
American Red Cross Blood Services, Farmington, Connecticut 06032.
Protein C is a plasma, vitamin K-dependent zymogen of a serine protease that can inhibit blood coagulation. Protein C is regulated by a series of reactions known as the protein C pathway. The importance of this pathway is seen in the occurrence of thrombosis in individuals with deficiencies in elements of the pathway like protein C and protein S. Work on several steps in this pathway has revealed that mechanisms involved in activation of protein C and the expression of its anticoagulant activity have features that allow for the expression of the anticoagulant activity away from sites in which procoagulant reactions occur, but not systemically. Thrombin, the principal procoagulant enzyme at the site of an injury, is converted to an anticoagulant enzyme at distant sites through its interaction with the endothelial cell protein thrombomodulin. Structural and functional studies have revealed the importance of several domain structures in the modulation of thrombin activity. Structural features of both activated protein C and its substrates (coagulation factors V and VIII) are such that they require the localization of enzyme and substrate on the surface of phosphatidyl serine containing membranes for optimum activity.
This article has been cited by other articles:
![]() |
J.-S. Bae, L. Yang, C. Manithody, and A. R. Rezaie The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cells Blood, December 1, 2007; 110(12): 3909 - 3916. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, J.-S. Bae, C. Manithody, and A. R. Rezaie Identification of a Specific Exosite on Activated Protein C for Interaction with Protease-activated Receptor 1 J. Biol. Chem., August 31, 2007; 282(35): 25493 - 25500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Bae, L. Yang, C. Manithody, and A. R. Rezaie Engineering a Disulfide Bond to Stabilize the Calcium-binding Loop of Activated Protein C Eliminates Its Anticoagulant but Not Its Protective Signaling Properties J. Biol. Chem., March 23, 2007; 282(12): 9251 - 9259. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Bae, L. Yang, and A. R. Rezaie Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells PNAS, February 20, 2007; 104(8): 2867 - 2872. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Panteleev, M. V. Ovanesov, D. A. Kireev, A. M. Shibeko, E. I. Sinauridze, N. M. Ananyeva, A. A. Butylin, E. L. Saenko, and F. I. Ataullakhanov Spatial Propagation and Localization of Blood Coagulation Are Regulated by Intrinsic and Protein C Pathways, Respectively Biophys. J., March 1, 2006; 90(5): 1489 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, C. Manithody, and A. R. Rezaie Activation of protein C by the thrombin-thrombomodulin complex: Cooperative roles of Arg-35 of thrombin and Arg-67 of protein C PNAS, January 24, 2006; 103(4): 879 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Sere, J. Rosing, and T. M. Hackeng Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance Blood, December 1, 2004; 104(12): 3624 - 3630. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, S. Prasad, E. Di Cera, and A. R. Rezaie The Conformation of the Activation Peptide of Protein C Is Influenced by Ca2+ and Na+ Binding J. Biol. Chem., September 10, 2004; 279(37): 38519 - 38524. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Castoldi, J. M. Brugge, G. A. F. Nicolaes, D. Girelli, G. Tans, and J. Rosing Impaired APC cofactor activity of factor V plays a major role in the APC resistance associated with the factor V Leiden (R506Q) and R2 (H1299R) mutations Blood, June 1, 2004; 103(11): 4173 - 4179. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Castoldi, J. W. P. Govers-Riemslag, M. Pinotti, D. Bindini, G. Tans, M. Berrettini, M. G. Mazzucconi, F. Bernardi, and J. Rosing Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation Blood, December 1, 2003; 102(12): 4014 - 4020. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamashita, A. Sekiguchi, Y.-k. Iwasaki, K. Sagara, S. Hatano, H. Iinuma, T. Aizawa, and L.-T. Fu Thrombomodulin and Tissue Factor Pathway Inhibitor in Endocardium of Rapidly Paced Rat Atria Circulation, November 18, 2003; 108(20): 2450 - 2452. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Rezaie and L. Yang Thrombomodulin allosterically modulates the activity of the anticoagulant thrombin PNAS, October 14, 2003; 100(21): 12051 - 12056. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, C. Manithody, T. D. Walston, S. T. Cooper, and A. R. Rezaie Thrombomodulin Enhances the Reactivity of Thrombin with Protein C Inhibitor by Providing Both a Binding Site for the Serpin and Allosterically Modulating the Activity of Thrombin J. Biol. Chem., September 26, 2003; 278(39): 37465 - 37470. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Manithody, P. J. Fay, and A. R. Rezaie Exosite-dependent regulation of factor VIIIa by activated protein C Blood, June 15, 2003; 101(12): 4802 - 4807. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yegneswaran, M. D. Smirnov, O. Safa, N. L. Esmon, C. T. Esmon, and A. E. Johnson Relocating the Active Site of Activated Protein C Eliminates the Need for Its Protein S Cofactor. A FLUORESCENCE RESONANCE ENERGY TRANSFER STUDY J. Biol. Chem., February 26, 1999; 274(9): 5462 - 5468. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. He and A. R. Rezaie Identification and Characterization of the Sodium-binding Site of Activated Protein C J. Biol. Chem., February 19, 1999; 274(8): 4970 - 4976. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Spek, V. J. Lannoy, F. P. Lemaigre, G. G. Rousseau, R. M. Bertina, and P. H. Reitsma Type I Protein C Deficiency Caused by Disruption of a Hepatocyte Nuclear Factor (HNF)-6/HNF-1 Binding Site in the Human Protein C Gene Promoter J. Biol. Chem., April 24, 1998; 273(17): 10168 - 10173. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bajzar, M. Nesheim, J. Morser, and P. B. Tracy Both Cellular and Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating the Activation of Thrombin-activable Fibrinolysis Inhibitor J. Biol. Chem., January 30, 1998; 273(5): 2792 - 2798. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Laszik, A. Mitro, F. B. Taylor Jr, G. Ferrell, and C. T. Esmon Human Protein C Receptor Is Present Primarily on Endothelium of Large Blood Vessels : Implications for the Control of the Protein C Pathway Circulation, November 18, 1997; 96(10): 3633 - 3640. [Abstract] [Full Text] |
||||
![]() |
S. Yegneswaran, G. M. Wood, C. T. Esmon, and A. E. Johnson Protein S Alters the Active Site Location of Activated Protein C above the Membrane Surface. A FLUORESCENCE RESONANCE ENERGY TRANSFER STUDY OF TOPOGRAPHY J. Biol. Chem., October 3, 1997; 272(40): 25013 - 25021. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Weisel, C. Nagaswami, T. A. Young, and D. R. Light The Shape of Thrombomodulin and Interactions with Thrombin as Determined by Electron Microscopy J. Biol. Chem., December 6, 1996; 271(49): 31485 - 31490. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Regan, L. M. O'Brien, T. L. Beattie, K. Sudhakar, F. J. Walker, and P. J. Fay Activated Protein C-catalyzed Proteolysis of Factor VIIIa Alters Its Interactions within Factor Xase J. Biol. Chem., February 23, 1996; 271(8): 3982 - 3987. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Rezaie, S. T. Cooper, F. C. Church, and C. T. Esmon Protein C Inhibitor Is a Potent Inhibitor of the Thrombin-Thrombomodulin Complex J. Biol. Chem., October 27, 1995; 270(43): 25336 - 25339. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Spek, J. S. Greengard, J. H. Griffin, R. M. Bertina, and P. H. Reitsma Two Mutations in the Promoter Region of the Human Protein C Gene Both Cause Type I Protein C Deficiency by Disruption of Two HNF-3 Binding Sites J. Biol. Chem., October 13, 1995; 270(41): 24216 - 24221. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bajzar, R. Manuel, and M. E. Nesheim Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor J. Biol. Chem., June 16, 1995; 270(24): 14477 - 14484. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Spek, T. Koster, F. R. Rosendaal, R. M. Bertina, and P. H. Reitsma Genotypic Variation in the Promoter Region of the Protein C Gene Is Associated With Plasma Protein C Levels and Thrombotic Risk Arterioscler. Thromb. Vasc. Biol., February 1, 1995; 15(2): 214 - 218. [Abstract] [Full Text] |
||||
![]() |
L. W. Hoyer Hemophilia A N. Engl. J. Med., January 6, 1994; 330(1): 38 - 47. [Full Text] |
||||
![]() |
A. R. Rezaie Vitronectin Functions as a Cofactor for Rapid Inhibition of Activated Protein C by Plasminogen Activator Inhibitor-1. IMPLICATIONS FOR THE MECHANISM OF PROFIBRINOLYTIC ACTION OF ACTIVATED PROTEIN C J. Biol. Chem., May 4, 2001; 276(19): 15567 - 15570. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |